Literature DB >> 7991618

Chemiluminescent activation of the antiviral activity of hypericin: a molecular flashlight.

S Carpenter1, M J Fehr, G A Kraus, J W Petrich.   

Abstract

Hypericin is a naturally occurring photosensitizer that displays potent antiviral activity in the presence of light. The absence of light in many regions of the body may preclude the use of hypericin and other photosensitizers as therapeutic compounds for the treatment of viral infections in vivo. The chemiluminescent oxidation of luciferin by the luciferase from the North American firefly Photinus pyralis was found to generate sufficiently intense and long-lived emission to induce antiviral activity of hypericin. Light-induced virucidal activity of hypericin was demonstrated against equine infectious anemia virus, a lentivirus structurally, genetically, and antigenically related to the human immunodeficiency virus. The implications for exploiting chemiluminescence as a "molecular flashlight" for effecting photodynamic therapy against virus-infected cells and tumor cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7991618      PMCID: PMC45419          DOI: 10.1073/pnas.91.25.12273

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo- and paramyxoviruses.

Authors:  O P Zhirnov
Journal:  Virology       Date:  1990-05       Impact factor: 3.616

2.  Photodynamic action in Stentor coeruleus sensitized by endogenous pigment stentorin.

Authors:  K C Yang; R K Prusti; E B Walker; P S Song; M Watanabe; M Furuya
Journal:  Photochem Photobiol       Date:  1986-03       Impact factor: 3.421

3.  Role of the host immune response in selection of equine infectious anemia virus variants.

Authors:  S Carpenter; L H Evans; M Sevoian; B Chesebro
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

Review 4.  Hypericin and its photodynamic action.

Authors:  N Durán; P S Song
Journal:  Photochem Photobiol       Date:  1986-06       Impact factor: 3.421

5.  Measurement of formal potentials for hypericin in dimethylsulfoxide.

Authors:  J Redepenning; N Tao
Journal:  Photochem Photobiol       Date:  1993-10       Impact factor: 3.421

6.  Spectroscopic characterization of the Stentor photoreceptor.

Authors:  E B Walker; T Y Lee; P S Song
Journal:  Biochim Biophys Acta       Date:  1979-09-20

7.  The chemiluminescence of firefly luciferin. A model for the bioluminescent reaction and identification of the product excited state.

Authors:  T A Hopkins; H H Seliger; E H White; M H Cass
Journal:  J Am Chem Soc       Date:  1967-12-20       Impact factor: 15.419

8.  Proton release from Stentor photoreceptors in the excited states.

Authors:  P S Song; E B Walker; R A Auerbach; G W Robinson
Journal:  Biophys J       Date:  1981-08       Impact factor: 4.033

9.  Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin.

Authors:  D Meruelo; G Lavie; D Lavie
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 10.  Virus entry into animal cells.

Authors:  M Marsh; A Helenius
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

View more
  17 in total

1.  Evaluation of firefly luciferase bioluminescence mediated photodynamic toxicity in cancer cells.

Authors:  Meike L Schipper; Manishkumar R Patel; Sanjiv S Gambhir
Journal:  Mol Imaging Biol       Date:  2006 Jul-Aug       Impact factor: 3.488

2.  Virucidal agents in the eve of manorapid synergy.

Authors:  Angel S Galabov
Journal:  GMS Krankenhhyg Interdiszip       Date:  2007-09-13

3.  Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin.

Authors:  R Kerb; J Brockmöller; B Staffeldt; M Ploch; I Roots
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

4.  Evaluation of the light-sensitive cytotoxicity of Hypericum perforatum extracts, fractions, and pure compounds.

Authors:  Laura A Schmitt; Yi Liu; Patricia A Murphy; Diane F Birt
Journal:  J Agric Food Chem       Date:  2006-04-19       Impact factor: 5.279

Review 5.  Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy.

Authors:  Zijian Zhou; Jibin Song; Liming Nie; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-11-21       Impact factor: 54.564

6.  Hypericum in infection: Identification of anti-viral and anti-inflammatory constituents.

Authors:  Diane F Birt; Mark P Widrlechner; Kimberly Dp Hammer; Matthew L Hillwig; Jingqiang Wei; George A Kraus; Patricia A Murphy; Joeann McCoy; Eve S Wurtele; Jeffrey D Neighbors; David F Wiemer; Wendy J Maury; Jason P Price
Journal:  Pharm Biol       Date:  2009       Impact factor: 3.503

7.  Identification of light-independent inhibition of human immunodeficiency virus-1 infection through bioguided fractionation of Hypericum perforatum.

Authors:  Wendy Maury; Jason P Price; Melinda A Brindley; ChoonSeok Oh; Jeffrey D Neighbors; David F Wiemer; Nickolas Wills; Susan Carpenter; Cathy Hauck; Patricia Murphy; Mark P Widrlechner; Kathleen Delate; Ganesh Kumar; George A Kraus; Ludmila Rizshsky; Basil Nikolau
Journal:  Virol J       Date:  2009-07-13       Impact factor: 4.099

8.  Catalytic therapy of cancer with ascorbate and extracts of medicinal herbs.

Authors:  Nadejda Rozanova Torshina; Jin Z Zhang; Diane E Heck
Journal:  Evid Based Complement Alternat Med       Date:  2007-12-26       Impact factor: 2.629

Review 9.  Antimicrobial photodynamic inactivation in nanomedicine: small light strides against bad bugs.

Authors:  Rui Yin; Tanupriya Agrawal; Usman Khan; Gaurav K Gupta; Vikrant Rai; Ying-Ying Huang; Michael R Hamblin
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

10.  Sonodynamic excitation of Rose Bengal for eradication of gram-positive and gram-negative bacteria.

Authors:  Faina Nakonechny; Michael Nisnevitch; Yeshayahu Nitzan; Marina Nisnevitch
Journal:  Biomed Res Int       Date:  2012-12-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.